HRH3 and Cognitive impairment: In addition, the UW-MD-72 derivative was developed and characterized as a reversible and competitive potent AChEI and as an H3R antagonist with a high selectivity profile, ameliorating cognitive impairments via mechanisms dependent on cholinergic muscarinic neurotransmission [24].